Edition:
United States

Nate Raymond

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

Apr 20 2018

Nonprofit sues over NIH licensing of cancer tech to Gilead

A nonprofit group is suing to challenge the National Institutes of Health's plan to grant a license on taxpayer-funded cancer treatment technology to a Gilead Sciences Inc unit, arguing the decision ignored the public's interest in affordable drugs.

Apr 20 2018

Ex-Aveo Pharmaceuticals CFO must face SEC trial, judge rules

A federal judge on Friday cleared the way for the U.S. Securities and Exchange Commission to take Aveo Pharmaceuticals Inc's former chief financial officer to trial over claims he misled investors in connection with the company's efforts to develop a cancer drug.

Apr 20 2018

U.S. biotech companies Alnylam, Dicerna settle trade secrets case

BOSTON Alnylam Pharmaceuticals Inc said on Friday that Dicerna Pharmaceuticals Inc will pay it $25 million in cash and stock to resolve a lawsuit claiming it stole trade secrets about gene-silencing technology used to develop drug treatments.

Apr 18 2018

Tenet beats class action stemming from kickback probe

A federal appeals court on Wednesday upheld the dismissal of a lawsuit seeking to force Tenet Healthcare to reimburse Hispanic women who were forced to go to its hospitals for prenatal services and to give birth due to a kickback scheme.

Apr 18 2018

SEC seeks to block ex-Aveo CFO's testimony about consulting counsel

The Securities and Exchange Commission is seeking to block the former chief financial officer of Aveo Pharmaceuticals Inc from testifying at his upcoming trial that he relied on lawyers before making statements the regulator claims were misleading.

Apr 18 2018

U.S. appeals court says Ohio cannot block Planned Parenthood funds

A federal appeals court on Wednesday blocked an Ohio law that would cut federal taxpayer funding to 28 Planned Parenthood clinics, holding that conditions it imposed that denied funds to abortion providers were unconstitutional.

Apr 17 2018

Opioid manufacturers to ask N.Y. judge to void counties' fee deals

Four opioid makers will ask a New York judge on Wednesday to block several counties accusing them of engaging in fraudulent marketing from using lawyers retained on a contingency-fee basis.

Apr 17 2018

Drugmaker Sellas discloses N.Y. federal opioid probe into doctors

Sellas Life Sciences Group Inc, which last year resolved a U.S. probe into allegations the drugmaker paid kickbacks to doctors to prescribe opioids, says federal prosecutors in Manhattan have issued it a subpoena seeking records related to specific physicians.

Apr 17 2018

Massachusetts top court declares stun gun ban unconstitutional

BOSTON The top court in Massachusetts on Tuesday struck down a state law that banned civilians from possessing stun guns, ruling unanimously that the law violated the U.S. Constitution's Second Amendment, which protects Americans' right to bear arms.

Apr 16 2018

Supreme Court seeks DOJ view on Gilead whistleblower case

The U.S. Supreme Court on Monday asked the solicitor general to weigh in on whether to grant review in a case involving Gilead Sciences Inc to consider what constitutes a material misrepresentation by companies submitting claims to the government for payment.

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary